Boston Scientific Corp.
(NYSE : BSX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.96%452.771.0%$898.46m
DHRDanaher Corp. -0.16%216.880.7%$617.91m
MDTMedtronic Plc 1.25%114.730.6%$550.81m
BSXBoston Scientific Corp. 0.09%33.581.0%$541.48m
ABTAbbott Laboratories 1.23%107.720.8%$518.84m
ISRGIntuitive Surgical, Inc. 0.48%729.822.3%$414.22m
DXCMDexCom, Inc. 1.81%318.217.8%$384.51m
BDXBecton, Dickinson & Co. 0.72%229.111.0%$348.04m
ALGNAlign Technology, Inc. 0.38%475.506.4%$319.43m
SYKStryker Corp. -0.30%233.021.3%$293.88m
BAXBaxter International, Inc. 0.86%76.041.8%$280.40m
EWEdwards Lifesciences Corp. 1.22%85.240.4%$229.69m
QDELQuidel Corp. 4.01%188.007.7%$222.25m
IDXXIDEXX Laboratories, Inc. 1.74%454.233.8%$216.71m
AAgilent Technologies, Inc. -0.22%114.101.6%$216.54m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.